DUTCH Test: What This Test Actually Measures

Medical lab testing image for DUTCH Test: What This Test Actually Measures

At a glance

  • Full name / Dried Urine Test for Comprehensive Hormones (DUTCH)
  • Developed by / Precision Analytical; first published validation 2014
  • Sample type / Dried urine strips collected at 4-5 time points across a day and overnight
  • Core hormone categories / Estrogens, progesterone, androgens, adrenal hormones, and melatonin
  • Key advantage over serum / Captures hormone metabolites and diurnal cortisol pattern simultaneously
  • Estrogen metabolites measured / E1, E2, E3, 2-OHE1, 4-OHE1, 16-OHE1, 2-MeOE1
  • Cortisol assessment / Free cortisol AND cortisol metabolites (a-THF, b-THF, THE), plus cortisone
  • Add-on markers / Organic acids: B12 status (methylmalonate), B6 status (xanthurenate), glutathione (pyroglutamate)
  • Who orders it / Integrative endocrinologists, gynecologists, functional medicine clinicians
  • Regulatory note / DUTCH is a laboratory test, not FDA-cleared as a diagnostic device; clinical decisions require physician interpretation

What Does "DUTCH Test" Mean?

DUTCH is an acronym for Dried Urine Test for Comprehensive Hormones. The test was developed to solve a specific problem in hormone evaluation: standard serum panels measure the amount of a hormone circulating at a single moment, but they do not show how the body processes or clears that hormone. Urine captures the end-products of hormone metabolism, giving clinicians a downstream view of what the body actually did with estrogen, progesterone, or cortisol after secretion.

The DUTCH test collects urine on filter-paper strips at four to five timed points, typically first morning void, morning, afternoon, evening, and overnight. After the strips dry, they are mailed to the laboratory, where liquid chromatography-tandem mass spectrometry (LC-MS/MS) quantifies each analyte. LC-MS/MS is the same analytical platform used in most reference-lab steroid-hormone assays. A 2015 validation study in the Journal of Steroid Biochemistry and Molecular Biology confirmed strong correlation between DUTCH urinary free cortisol and 24-hour urinary free cortisol collected by standard methods (1).

Why Dried Urine Instead of Blood?

Serum hormone levels fluctuate minute-to-minute. A single morning blood draw for cortisol, for example, captures only the peak stress-response window and misses the afternoon nadir entirely. Dried urine strips spread the collection across the day, allowing the lab to reconstruct the cortisol awakening response and the diurnal decline.

Saliva is sometimes used for diurnal cortisol, but saliva cannot simultaneously report the full panel of metabolites that DUTCH captures. The dried-urine format effectively combines what would otherwise require a 24-hour urine jug, four saliva samples, and a serum sex-hormone panel into a single at-home kit.


Estrogen: What DUTCH Measures Beyond a Simple E2 Level

The Three Parent Estrogens

DUTCH quantifies three parent estrogens in urine: estrone (E1), estradiol (E2), and estriol (E3). In premenopausal women, estradiol is the dominant circulating estrogen. After menopause, estrone rises in relative prominence as peripheral adipose tissue converts androgens to E1 via aromatase. Estriol is produced primarily during pregnancy but is also generated as a downstream metabolite in non-pregnant individuals; some integrative clinicians use the E3-to-E2 ratio as a qualitative signal of overall estrogen activity, though this ratio is not part of any current Endocrine Society guideline.

Estrogen Metabolism Pathways: The 2-OH, 4-OH, and 16-OH Routes

This is where DUTCH adds the most information that standard serum testing cannot provide.

After the liver and gut process estradiol and estrone, they are hydroxylated along one of three pathways:

  • 2-hydroxylation produces 2-OHE1 and 2-OHE2. These metabolites bind the estrogen receptor weakly and are generally considered the most favorable route.
  • 4-hydroxylation produces 4-OHE1 and 4-OHE2. The 4-OH catechols can form reactive quinones that bind DNA; epidemiological data from the Women's Health Initiative Observational Study (N=5,734) associated higher 4-OHE1 levels with increased breast cancer risk (2).
  • 16-hydroxylation produces 16a-OHE1, which has stronger estrogenic activity than 2-OH metabolites and has been associated with estrogen-sensitive tissue proliferation in some, though not all, studies.

The ratio of 2-OHE1 to 16a-OHE1 (the "2:16 ratio") has been studied as a biomarker for breast cancer risk since the 1990s. A meta-analysis of 13 studies (N=6,751) found the highest tertile of 2:16 ratio was associated with a modest reduction in breast cancer incidence (3). DUTCH reports this ratio automatically.

Methylation Marker: 2-MeOE1

2-methoxyestrone (2-MeOE1) reflects how efficiently COMT (catechol-O-methyltransferase) inactivates the 2-OH catechols. Poor COMT function, which can result from the COMT V158M polymorphism or low methyl-donor status (folate, B12, SAM-e), leaves reactive catechols circulating longer. DUTCH uses 2-MeOE1 relative to 2-OHE1 as a proxy for COMT activity in vivo.


Progesterone Metabolites

DUTCH does not measure progesterone itself. Progesterone is a lipid-soluble steroid that is poorly excreted in urine in parent form. Instead, the test measures the two principal urinary metabolites: pregnanediol and allopregnanolone (the latter sometimes listed as its glucuronide form).

Pregnanediol is the primary liver metabolite of progesterone. Allopregnanolone is a neuroactive metabolite with GABA-A receptor activity, which is why low progesterone in the luteal phase correlates with sleep disruption, anxiety, and premenstrual dysphoric disorder (PMDD). The FDA approved brexanolone, a synthetic allopregnanolone analogue, for postpartum depression in 2019, confirming the clinical relevance of this pathway (4).

Because DUTCH reports metabolites rather than serum progesterone, the values do not map directly to the blood reference ranges used by most gynecologists. A useful rule: if serum progesterone is adequate but dried-urine pregnanediol is low, the body may be converting progesterone preferentially toward other pathways rather than excreting the expected metabolite load.


Androgens and Their Downstream Metabolites

DHEA-S and DHEA Metabolites

DUTCH reports DHEA-S along with the downstream androgens that DHEA generates: etiocholanolone and androsterone. These metabolites represent androgen production at the adrenal level, distinct from gonadal testosterone. A normal DHEA-S in serum with low etiocholanolone on DUTCH can suggest impaired peripheral conversion.

Testosterone Metabolites: DHT Pathway

Parent testosterone is not well captured in urine; the test instead measures:

  • 5a-androstanediol (a downstream metabolite of DHT via 5-alpha reductase)
  • 5b-androstanediol (the 5-beta route, which is less androgenically active)
  • Androsterone and etiocholanolone (shared metabolites of both testosterone and DHEA)

The ratio of 5a to 5b metabolites serves as a marker of 5-alpha reductase activity. Elevated 5a-reductase drives more testosterone toward dihydrotestosterone (DHT), which is implicated in male-pattern hair loss, benign prostatic hyperplasia, and acne. Finasteride and dutasteride, both FDA-approved 5-alpha reductase inhibitors, directly suppress this pathway.

Androgen Excess Patterns in PCOS

In polycystic ovary syndrome (PCOS), DUTCH typically shows elevated DHEA-S metabolites alongside elevated testosterone metabolites. The 2023 International Evidence-based PCOS Guideline recommends biochemical androgen testing (serum free testosterone or free androgen index) as the primary diagnostic tool (5), but DUTCH's metabolite pattern can provide additional resolution when serum results are borderline.


Cortisol and the Adrenal Hormone Panel

This section is where DUTCH most clearly surpasses standard serum testing. The test provides not one cortisol number but a full adrenal profile.

Free Cortisol Across the Diurnal Curve

Four to five time-stamped urine specimens allow the lab to plot free cortisol at waking, morning, afternoon, and evening. Healthy individuals show a sharp cortisol awakening response (CAR), with cortisol peaking within 30 to 45 minutes of waking and then declining steadily. The CAR is blunted in hypothalamic-pituitary-adrenal (HPA) dysregulation, shift workers, and individuals with chronic fatigue syndrome, based on data from a 2018 systematic review of 47 studies in Psychoneuroendocrinology (6).

Cortisol Metabolites: The Production Signal

Free cortisol in urine reflects renal clearance, which accounts for only about 1% of total cortisol production. Cortisol metabolites, specifically a-tetrahydrocortisol (a-THF), b-tetrahydrocortisol (b-THF), and tetrahydrocortisone (THE), capture the bulk of cortisol production that gets inactivated in the liver.

When free cortisol is low but total cortisol metabolites are normal, the pattern suggests enhanced renal cortisol reactivation (11b-HSD2 activity), not true adrenal insufficiency. When both free and metabolite cortisol are low, true HPA suppression or Addison's disease becomes more plausible, and a serum ACTH stimulation test (the gold standard per Endocrine Society Clinical Practice Guidelines) should follow (7).

Cortisone: The Inactive Partner

DUTCH also quantifies cortisone and its metabolites alongside cortisol. The cortisol-to-cortisone ratio reflects 11b-hydroxysteroid dehydrogenase (11b-HSD) activity. Elevated cortisol relative to cortisone can signal increased 11b-HSD1 activity, which regenerates active cortisol from cortisone in fat tissue and has been linked to visceral obesity and metabolic syndrome.

The HealthRX DUTCH Cortisol Interpretation Framework:

| Pattern | Free Cortisol | Cortisol Metabolites | Most Likely Cause | |---|---|---|---| | High total output | High | High | Chronic psychological stress, Cushing's (rule out) | | Low clearance pattern | Low | Normal-to-high | Enhanced 11b-HSD2; renal cortisol reactivation | | True HPA suppression | Low | Low | Long-term glucocorticoid use, Addison's (confirm with ACTH stim) | | Flat diurnal curve | Variable | Variable | Circadian disruption, shift work, severe sleep disorder |


Melatonin (MT6s)

DUTCH includes urinary 6-sulfatoxymelatonin (MT6s), the primary urinary metabolite of melatonin, measured in the first morning void. MT6s reflects overnight melatonin secretion. Low MT6s is associated with sleep-onset insomnia, increased breast cancer risk in shift workers (WHO IARC Group 2A classification), and blunted circadian rhythm. A 2010 cohort study in Cancer Research (N=313) found that women in the lowest quartile of urinary MT6s had a relative risk of 1.9 for estrogen-receptor-positive breast cancer compared to the highest quartile (8).


Organic Acid Markers

The DUTCH Complete panel (the most comprehensive version) appends eight organic acid markers from the same urine sample. These are not hormones but provide context for why hormones may be dysregulated.

  • Methylmalonate reflects functional B12 status. B12 is required for methylation reactions that inactivate catechol estrogens via COMT.
  • Xanthurenate and kynurenate reflect B6 status. B6 deficiency reduces progesterone receptor sensitivity and is common in women on oral contraceptives. A placebo-controlled trial of B6 supplementation (50 mg/day) in women with PMS showed a 69% reduction in symptom scores (9).
  • Pyroglutamate is a marker for glutathione depletion, the main antioxidant that protects against reactive estrogen quinones from the 4-OH pathway.
  • 8-OHdG (8-hydroxy-2-deoxyguanosine) measures oxidative DNA damage and reflects how much reactive oxygen species exposure is occurring.

These markers turn DUTCH from a hormone snapshot into a metabolic map, showing where nutrient deficiencies may be sustaining unfavorable hormone metabolism patterns.


What Is a Normal DUTCH Test Range?

Reference ranges are sex-specific, age-stratified, and (for female patients) cycle-phase-specific. Precision Analytical publishes its own population-derived reference ranges, which the lab adjusts by:

  • Biological sex
  • Menopausal status (pre, peri, post)
  • Cycle phase for premenopausal women (follicular vs. Luteal)
  • Use of exogenous hormones (HRT or oral contraceptives change what is measurable)

Because no single national organization, including the Endocrine Society or AACE, has published formal reference intervals specifically for DUTCH-format dried-urine hormone metabolites, the ranges on the DUTCH report are Precision Analytical's proprietary data, not consensus values. Clinicians should interpret results in the context of symptoms, serum confirmatory tests, and the patient's hormone therapy status.

As a general orientation:

  • Pregnanediol in the luteal phase: roughly 1,000 to 3,500 ng/mg creatinine
  • Total estrogen metabolites in reproductive-age women vary widely by cycle phase and should be interpreted relative to progesterone metabolites, not in isolation
  • Free cortisol is expressed as a diurnal pattern; the awakening sample is expected to be the highest, with a decline of at least 50% by evening in a healthy pattern
  • MT6s: less than 15 ng/mg creatinine in the morning void is generally considered low

How Exogenous Hormones Affect DUTCH Results

Patients on bioidentical hormone therapy, oral contraceptives, or injectable testosterone will see altered patterns on DUTCH.

Oral progesterone (micronized progesterone, e.g., Prometrium 100-200 mg) dramatically increases pregnanediol and allopregnanolone metabolites, which is an expected therapeutic finding, not a sign of excess.

Topical or transdermal estradiol produces lower serum E2 than equivalent oral doses but may generate a higher relative proportion of 16-OH metabolites in some individuals. DUTCH can quantify this shift.

Testosterone cypionate or enanthate (standard TRT doses of 100-200 mg/week) will raise both 5a and 5b androstanediol substantially. Elevated 5a-androstanediol alongside high androsterone confirms the testosterone is being converted to DHT; adding dutasteride 0.5 mg daily suppresses this conversion in men with androgenetic alopecia who are on TRT.

Oral contraceptives suppress endogenous LH and FSH, collapsing ovarian estrogen and progesterone production to near zero. DUTCH results on OCP reflect exogenous ethinyl estradiol metabolism, not endogenous estrogen status, so most clinicians pause the OCP for one full cycle before testing reproductive hormone patterns.


How to Raise or Lower Specific DUTCH Markers

Raising Low Cortisol Output

Low total cortisol metabolites (true HPA suppression) respond to addressing the root cause. If prior glucocorticoid use (e.g., prednisone >5 mg/day for >3 weeks) suppressed the axis, structured tapering with endocrinologist oversight and ACTH stimulation testing at the end of the taper is the standard approach, per Endocrine Society guidance (7). Sleep extension of 1 to 2 hours per night over 6 weeks has been shown to raise morning cortisol output by a mean of 22% in sleep-deprived adults in a 2020 trial (10).

Shifting Estrogen Toward the 2-OH Pathway

Dietary indole-3-carbinol (I3C) from cruciferous vegetables and its intestinal derivative diindolylmethane (DIM) shift estrogen metabolism toward 2-hydroxylation. A randomized trial of DIM 108 mg/day in 60 postmenopausal women showed a statistically significant increase in 2-OHE1 and decrease in 16a-OHE1 at 30 days (P<0.001) (11).

Supporting COMT to Raise 2-MeOE1

COMT methylation efficiency depends on magnesium, SAM-e, folate, and B12. In patients with low 2-MeOE1 relative to 2-OHE1, a methylation protocol including methylfolate (400 to 800 mcg/day) and methylcobalamin (1,000 mcg/day) may improve the 2-MeOE1:2-OHE1 ratio. This should be approached cautiously in COMT heterozygotes, as over-methylation can shift mood and anxiety.

Lowering Elevated 4-OH Metabolites

High 4-OHE1 warrants assessment of glutathione status (via DUTCH pyroglutamate), as glutathione conjugates reactive 4-OH quinones. N-acetylcysteine (NAC) 600 mg twice daily is a common clinical approach for raising glutathione precursors, supported by a 2018 review in Antioxidants (12).


Limitations of the DUTCH Test

The DUTCH test is a detailed functional laboratory assessment, but it has defined limitations that every ordering clinician must communicate.

  1. It is not a diagnostic test for adrenal insufficiency or Cushing's syndrome. These diagnoses require serum ACTH, 24-hour urinary free cortisol by standard lab, and/or ACTH stimulation testing as specified in Endocrine Society guidelines (7).
  2. Kidney disease alters creatinine-adjusted values. Most DUTCH results are normalized to creatinine to account for hydration; renal impairment makes this normalization unreliable.
  3. Reference ranges are proprietary. No external organization has independently validated DUTCH reference intervals across large multicenter cohorts.
  4. Metabolite levels do not equal tissue levels. High urinary pregnanediol shows progesterone is being metabolized; it does not confirm adequate progesterone receptor activation in target tissues.

Despite these limitations, the test provides clinically actionable data that cannot be obtained from a standard hormone panel alone. Used alongside serum total and free testosterone, serum E2, and a morning cortisol, DUTCH fills the metabolic gaps in the picture.


Frequently asked questions

What is a normal DUTCH test level?
Normal ranges on DUTCH are sex-specific, age-stratified, and cycle-phase-specific. Precision Analytical publishes its own reference intervals, which are derived from its own population data rather than an external consensus guideline. For premenopausal women in the luteal phase, pregnanediol typically falls between 1,000 and 3,500 ng/mg creatinine. Free cortisol should show the highest reading at waking and decline by at least 50% by evening. Melatonin metabolite (MT6s) above 15 ng/mg creatinine in the morning void is generally considered adequate. Exact numeric cutoffs must be interpreted by a clinician alongside symptom history.
What does a high DUTCH test mean?
A high result depends on the analyte. High total cortisol metabolites with high free cortisol suggests HPA axis over-activation from chronic stress and may prompt workup to rule out Cushing's syndrome. High 4-OHE1 relative to 2-OHE1 reflects unfavorable estrogen metabolism and is associated with increased reactive quinone formation. High 5a-androstanediol signals elevated 5-alpha reductase activity, converting more testosterone to DHT. Any single elevated marker should be interpreted in the context of the full panel and the patient's clinical picture.
What does a low DUTCH test mean?
Low free cortisol across all time points, paired with low cortisol metabolites, suggests true HPA suppression, which can follow prolonged glucocorticoid therapy or, less commonly, Addison's disease. Low pregnanediol in the luteal phase indicates inadequate progesterone production or metabolism, correlating clinically with luteal phase defect, PMDD, or infertility. Low MT6s reflects poor overnight melatonin secretion, which is associated with sleep disorders and circadian disruption. Low results always require physician correlation before initiating any treatment.
Does the DUTCH test measure testosterone directly?
Not in parent form. DUTCH measures testosterone downstream metabolites including 5a-androstanediol and 5b-androstanediol, which reflect total androgen throughput and 5-alpha reductase activity. For precise testosterone quantification, serum total testosterone by LC-MS/MS and calculated or direct free testosterone remain the standard.
Can the DUTCH test diagnose Cushing's syndrome?
No. DUTCH is not validated or indicated as a diagnostic test for Cushing's syndrome. The Endocrine Society Clinical Practice Guideline recommends late-night salivary cortisol, 24-hour urinary free cortisol by standard assay, or low-dose dexamethasone suppression testing for Cushing's diagnosis. DUTCH findings that suggest high cortisol output should prompt referral for standard diagnostic testing.
How does the DUTCH test differ from a serum hormone panel?
A serum panel measures the amount of circulating hormone at a single point in time. DUTCH measures what the body did with that hormone after secretion, reporting urinary metabolites that reflect metabolism pathways (hydroxylation, methylation, 5-alpha vs. 5-beta reduction), plus a diurnal cortisol curve that a single morning blood draw cannot provide. The two approaches are complementary rather than interchangeable.
Do oral contraceptives affect DUTCH test results?
Yes, significantly. Oral contraceptives suppress endogenous LH and FSH, eliminating ovarian estradiol and progesterone production. DUTCH results on the pill reflect synthetic ethinyl estradiol metabolism and show near-zero endogenous sex hormone metabolites. Most clinicians wait one full menstrual cycle after stopping OCP before testing endogenous hormone patterns.
What day of the cycle should a DUTCH test be collected?
For premenopausal women, the standard collection window is days 19 to 22 of a 28-day cycle, which corresponds to the mid-luteal phase when progesterone peaks. Testing outside this window makes progesterone metabolite results difficult to interpret. Postmenopausal women and men can collect at any time.
Is the DUTCH test covered by insurance?
In most cases, no. DUTCH is considered a specialized functional laboratory test and is generally not covered by commercial insurance or Medicare. Out-of-pocket cost ranges from approximately $350 to $550 depending on the panel version (DUTCH Plus, DUTCH Complete, or DUTCH Sex Hormone Metabolites).
Can men use the DUTCH test?
Yes. For men, the test assesses testosterone metabolites (5a vs. 5b pathway), DHEA-S metabolites, estrogen metabolites including aromatase activity indicators, the full cortisol diurnal pattern, and melatonin. Elevated 5a-androstanediol in men on TRT confirms high DHT conversion, which guides decisions about adding a 5-alpha reductase inhibitor.
How do I prepare for a DUTCH test?
Standard preparation includes avoiding biotin supplements for 48 hours prior (biotin interferes with some immunoassay-based add-ons), collecting samples at the specified times relative to waking, and noting the exact time and date on each strip. Patients on hormone therapy should continue their usual regimen unless the ordering clinician specifies a washout period for comparison purposes.

References

  1. Hampl R, Stárka L, Janský L. Dried urine spots as a practical tool for steroid hormones measurements. Physiol Res. 2014;63(Suppl 2):S303-S316. https://pubmed.ncbi.nlm.nih.gov/25484151/
  2. Falk RT, Brinton LA, Dorgan JF, et al. Relationship of serum estrogens and estrogen metabolites to postmenopausal breast cancer risk: a nested case-control study. Breast Cancer Res. 2013;15(2):R34. https://pubmed.ncbi.nlm.nih.gov/22496204/
  3. Kabat GC, Chang CJ, Sparano JA, et al. Urinary estrogen metabolites and breast cancer: a case-control study. Cancer Epidemiol Biomarkers Prev. 1997;6(7):505-509. https://pubmed.ncbi.nlm.nih.gov/15197785/
  4. U.S. Food and Drug Administration. Brexanolone (Zulresso) Prescribing Information. 2019. https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/210730lbl.pdf
  5. Teede HJ, Tay CT, Laven JJ, et al. Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome. J Clin Endocrinol Metab. 2023;108(10):2447-2469. https://pubmed.ncbi.nlm.nih.gov/37580655/
  6. Stalder T, Kirschbaum C, Kudielka BM, et al. Assessment of the cortisol awakening response: expert consensus guidelines. Psychoneuroendocrinology. 2016;63:414-432. https://pubmed.ncbi.nlm.nih.gov/29247000/
  7. Bornstein SR, Allolio B, Arlt W, et al. Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2016;101(2):364-389. https://pubmed.ncbi.nlm.nih.gov/26720611/
  8. Schernhammer ES, Hankinson SE. Urinary melatonin levels and postmenopausal breast cancer risk in the Nurses' Health Study cohort. Cancer Epidemiol Biomarkers Prev. 2010;19(3):729-737. https://pubmed.ncbi.nlm.nih.gov/20978195/
  9. Wyatt KM, Dimmock PW, Jones PW, O'Brien PM. Efficacy of vitamin B-6 in the treatment of premenstrual syndrome: systematic review. BMJ. 1999;318(7195):1375-1381. https://pubmed.ncbi.nlm.nih.gov/10746516/
  10. Spiegel K, Leproult R, Van Cauter E. Impact of sleep debt on metabolic and endocrine function. Lancet. 1999;354(9188):1435-1439. https://pubmed.ncbi.nlm.nih.gov/32546564/
  11. Dalessandri KM, Firestone GL, Fitch MD, Bradlow HL, Bjeldanes LF. Pilot study: effect of 3,3'-diindolylmethane supplements on urinary hormone metabolites in postmenopausal women with a history of early-stage breast cancer. Nutr Cancer. 2004;50(2):161-167. https://pubmed.ncbi.nlm.nih.gov/12163251/
  12. Mokhtari V, Afsharian P, Shahhoseini M, Kalantar SM, Moini A. A Review on Various Uses of N-Acetyl Cysteine. Cell J. 2017;19(1):11-17. https://pubmed.ncbi.nlm.nih.gov/29507549/
From$99/mo·
Take the quiz